Microsoft® CRM 3.0
RHO was founded in 1984 to provide biostatistical and data management services for clinical research. Eleven years later, RHO implemented their proprietary clinical data management system designed to ensure quality during each step of the process. In 2001, RHO began work on their first FDA submission and was accepted for review 100 percent. Then, in 2002, they began their first adaptive design trial on two types of staph infections in premature babies in which their early adoption of adaptive design positioned them as industry leaders with a world-class biostatistical group. A year later RHO initiates work on their first international trial dedicated to increasing understanding of factors that regulate development of immune intolerance as part of the Hemophilia Inhibitor Genetics Study. In 2004, RHO started implementing CDISC standards in submission deliverables and by using their industry-leading CDISC tools, they provided better efficiencies to their clients. Then, in 2008, the National Institute of Allergy and Infectious Diseases awarded RHO a 6-year contract to provide biostatistical, data management, and safety services for the Immune Tolerance Network (ITN) and the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC).
“Microsoft® CRM 3.0 allows a company’s sales and marketing team to track
every customer interaction from the familiar Outlook interface.”
– Dan Michaels, Innovative Architects